Position in AZN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$48,361,253
-$2,021,948 QoQ
Shares Held
255,043
-0.2% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#161
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026USS Investment Management Ltd holds $724,325,860 across 10 Drug Manufacturers - General names. AZN ranks #5 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,014,246 | $257,588,056 | |
| 2 | LLY |
ELI LILLY & Co
|
139,687 | $167,544,792 | |
| 3 | ABBV |
AbbVie Inc.
|
300,376 | $75,586,616 | |
| 4 | MRK |
Merck & Co., Inc.
|
432,343 | $55,556,075 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
255,043 | $48,361,253 | |
| 6 | AMGN |
Amgen Inc
|
96,817 | $35,059,372 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
225,951 | $28,546,649 | |
| 8 | PFE |
Pfizer Inc
|
999,888 | $24,077,303 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,361,253 | 255,043 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $50,383,201 | 255,467 | Shares | Sole | 2026-04-24 | |
| No filing history on record for this holder in this stock. | ||||||